Consistent with CXCR4 expression being downstream of PAX3-FOXO1 transgene expression, CXCR4 expression in RMS correlates with the ARMS histology, unfavorable primary site, advanced disease at diagnosis and bone marrow involvement [100]. This evidence concerns the gene CXCR4 and alveolar rhabdomyosarcoma.